SAN FRANCISCO – Among the companies whose shares are expected to see active trade in Wednesday's session are Intel Corp., Hovnanian Enterprises Inc. and Ford Motor Co.
Casella Waste Systems (CWST) is expected to report a fiscal first-quarter net loss of 3 cents a share, according to analysts polled by Thomson First Call.
Champps Entertainment (CMPP) is expected to post a fiscal fourth-quarter net loss of a penny a share.
Dollar Financial Corp.'s (DLLR) fiscal fourth-quarter profit is expected to be 33 cents a share.
Global Crossing (GLBC) is expected to post a fiscal third-quarter per-share loss of $1.52.
Hovnanian (HOV) is expected to report fiscal third-quarter net earnings of $1.10 a share.
Spartech Corp. (SEH) is expected to post a per-share profit of 34 cents in its fiscal third quarter.
After Tuesday's closing bell, Intel (INTC) said it will cut 10,500 jobs, or about 10% of its work force, by the middle of 2007 as it looks to slash costs and boost profits amid stiffer competition from smaller rival Advanced Micro Devices Inc. (AMD).
Ford (F) named Alan Mulally, a senior executive at Boeing Co. (BA) , to take the reins from current Chief Executive Bill Ford as the automaker works to quicken the pace of its massive "Way Forward" overhaul.
Altera Corp. (ALTR) said it still expects third-quarter sales of $334 million to $344 million.
Autodesk Inc. (ADSK) said it doesn't expect to be able to file on time its report on its quarterly results with regulators due to a previously announced review of its practices for granting stock-options.
Bob Evans Farms Inc. (BOBE) said same-store sales at Bob Evans Restaurants for August fell 4.2% from the same period a year ago. Monthly average menu prices rose 3%.
Casey's General Stores Inc. (CASY) said first-quarter net income fell as the company faced "a challenging gasoline environment." The Iowa-based concern said quarterly net profit was $16.9 million, or 33 cents a share, compared with $20.9 million, or 41 cents a share, during the same period in the prior year.
Catalyst Semiconductor Inc. (CATS) said it swung to a first-quarter net loss on lower gross margins and the impact of stock-option compensation expense. The Santa Clara, Calif.-based company said the quarterly net loss was $228,000, or a penny a share. During the same period in the prior year, the company reported net income of $495,000, or 3 cents a share.
Donaldson Co. (DCI) said fourth-quarter net income rose to $36.2 million, or 43 cents a share, from $25.1 million, or 29 cents a share, during the same period in the prior year. Quarterly revenue was $468.2 million, compared with $422.7 million in the prior year.
Emulex Corp. (ELX) named James McCluney president and chief executive. McCluney had been president and chief operating officer of the Costa Mesa, Calif.-based provider of storage networking connectivity products.
Finisar Corp. (FNSR) reported a first-quarter net loss of $820,000, or breakeven on a per-share basis, compared with a net loss of $19.1 million, or 7 cents a share, during the year-ago period. The optical equipment company posted revenue of $106.2 million, up 30% from $81.7 million a year ago.
Forest Oil Corp. (FST) said it now expects 2006 production to average between 305 million and 320 million of cubic feet equivalent per day. Forest Oil also estimated that capital expenditures for exploration and development will be around $580 million in 2006, up $80 million from the previous forecast.
Hain Celestial Group Inc. (HAIN) said it swung to profit in the fourth quarter on increased demand.
Hooker Furniture Corp. (HOFT) said President and Chief Operating Officer Doug Williams will retire at the end of October. Williams' responsibilities will be carried out by Chief Executive Officer Paul Toms Jr. and others on the executive management team.
Intervoice Inc. (INTV) said it now expects its second-quarter revenue to be near or slightly above the top end of the previously announced range of $44 million to $49 million.
Specialty chemical-maker MacDermid Inc. (MRD) said it received a proposal letter from its chairman and chief executive Daniel Leever and Court Square Capital Partners to purchase all of its outstanding common stock for $32.50 a share.
Nuvelo Inc. (NUVO) said a study has shown its rNAPc2 recombinant protein cut the incidence and duration of ischemia without an increase in clinically significant bleeding. The Phase II trial data showed a positive response in patients with acute coronary syndromes taking the protein both in combination with heparin and without heparin.
PlanetOut Inc. (LGBT) said it now expects third-quarter revenue of $15 million to $16 million, down about 14% from its previous forecast. The San Francisco-based media company also lowered its outlook for adjusted earnings before interest, taxes, depreciation and amortization to between flat and $1 million.
Procter & Gamble Co. (PG) said it has filed a lawsuit against HABA-Davion Inc. for trade dress and trademark infringement involving several of its personal care brands. Procter & Gamble said the suit involves its Secret, Old Spice Red Zone and High Endurance brands.
Sara Lee Corp. (SLE) said it has completed the spinoff of Hanesbrands Inc. (HBI) to its shareholders. The Chicago-based company said it plans to distribute one share of Hanesbrands stock for every eight Sara Lee shares owned to shareholders of record as of Aug. 18.
Smith & Wollensky Restaurant Group Inc. (SWRG) said August comparable restaurant sales rose 7.1% to $7.8 million from $7.3 million during the same month in the prior year. Total monthly restaurant sales were $8.3 million, up 5.3% from the prior year.
TiVo Inc. (TIVO) said it launching a follow-on public offering of 8.26 million primary shares.
UAL Corp.'s (UAUA) United Airlines said preliminary traffic for August rose 1.5% to 10.6 billion from 10.4 billion revenue passenger miles during the same period in the prior year.
With growth driven by new products, Wendy's International Inc. (WEN) said preliminary same-store sales for August jumped nearly 5% to their highest rate in more than two years. See full story.
ZymoGenetics Inc. (ZGEN) said a Phase III trial of its recombinant human Thrombin, or rhThrombin, met its primary endpoint. The Seattle-based biotechnology company is developing rhThrombin as a standalone product for use as a topical hemostat to control surgical bleeding.
Copyright (c) 2006 MarketWatch, Inc.